A New Reverse-Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Fimasartan, Rosuvastatin Calcium, and Amlodipine Besylate in Combination

Rujuta Prashant Mistry,Chainesh Shah,Rakesh Jat
DOI: https://doi.org/10.1007/s11094-022-02644-9
2022-05-27
Pharmaceutical Chemistry Journal
Abstract:A reverse-phase high performance liquid chromatography (RP-HPLC) method was developed and validated for simultaneous estimation of fimasartan (FIM), amlodipine besylate (AML) and rosuvastatin calcium (ROS) in combination for the treatment of hypertension with dyslipidemia presenting a major risk factor for cardiovascular diseases Chromatographic separation was performed on stationary reverse-phase inert sustain-swift C 18 100A° (250 mm × 4.6 mm, 5 μm i.d.) column. The optimized mobile phase acetonitrile – methanol – water (15:15:70, v/v, at pH 3.5 adjusted with 0.1% ortho-phosphoric acid) was pumped at a flow rate of 1.0 mL/min and the effluent spectrum was monitored at 230 nm. Calibration graphs of drugs constructed at their wavelengths of determination were linear in a concentration range of 10 – 100 μg/mL for all three components. The retention times for FIM, ROS calcium, and AML peaks at 230 nm were found to be 4.6, 6.4, and 10.8 min respectively The method suggested usefulness of a unique mobile phase during the estimation of two or more multicomponent dosage forms. Due to its simplicity, rapidness, high precision, and accuracy, the proposed RP-HPLC method can be applied for simultaneous determination of FIM, ROS and AML in bulk mixture.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?